Aipeng Medical announced that the company and Jiangsu Yingjue Private Equity Fund Management Co., Ltd. and Jiaxing Silin Venture Capital Partnership have jointly invested to establish the Aipeng Smart Chain Yunnao Equity Investment Partnership. As a limited partner, the company subscribed to the investment fund share with its own capital of RMB 49.7 million, with an investment ratio of 49.7%. The fund mainly invests in equity in brain-computer interface, neuroscience, psychiatric diseases, and other healthcare fields. The investment period is 4 years, and the duration is 7 years.

Aipeng Medical announced that the company and Jiangsu Yingjue Private Equity Fund Management Co., Ltd. and Jiaxing Silin Venture Capital Partnership have jointly invested to establish the Aipeng Smart Chain Yunnao Equity Investment Partnership. As a limited partner, the company subscribed to the investment fund share with its own capital of RMB 49.7 million, with an investment ratio of 49.7%. The fund mainly invests in equity in brain-computer interface, neuroscience, psychiatric diseases, and other healthcare fields. The investment period is 4 years, and the duration is 7 years.